Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11879963 | 0.97 | ALDH1A1 (0.60) | ALDH1A1TP53TDP1 | |
| SCHEMBL11172731 | 0.84 | — | — | |
| SCHEMBL8460588 | 0.81 | — | — | |
| SCHEMBL26896 | 0.78 | ALDH1A1 (1.00) | ALDH1A1TP53TDP1 | |
| SCHEMBL499601 | 0.75 | ALDH1A1 (0.94) | ALDH1A1TP53 | |
| Hydrochloric Acid SCHEMBL21956045 | 0.75 | ALDH1A1 (0.94) | ALDH1A1TP53 | |
| SCHEMBL17333232 | 0.75 | ALDH1A1 (0.63) | ALDH1A1TP53 | |
| SCHEMBL11419113 | 0.75 | ALDH1A1 (0.55) | ALDH1A1TP53TDP1 | |
| SCHEMBL3298770 | 0.73 | — | — | |
| SCHEMBL4906432 | 0.73 | ALDH1A1 (0.60) | ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3987129-A | PROCESS FOR PREPARING BIS(2-HALOALKYL) PHOSPHORO-HALIDATES | OLIN CORPORATION (US) | 1976-10-19 | — | — | US | claimed |
| EP-4744667-A2 | EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF | The Queen's University Of Belfast (GB) | 2026-05-20 | — | — | EP | disclosed |
| US-20250163093-A1 | EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2025-05-22 | — | — | US | disclosed |
| CN-110662542-B | Nicotinoyl nucleosides and reduced nicotinoyl nucleosides, modified derivatives thereof, phosphorylated analogs thereof, adenosine dinucleotide conjugates thereof, and efficient and scalable synthesis of novel crystalline forms thereof | 英国贝尔法斯特女王大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-119320417-A | Nicotinoyl nucleosides and reduced nicotinoyl nucleosides, modified derivatives thereof, phosphorylated analogs, adenosine dinucleotide conjugates, and efficient and scalable synthesis of novel crystalline forms | 英国贝尔法斯特女王大学 | 2025-01-17 | — | — | CN | disclosed |
| US-12195494-B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2025-01-14 | — | — | US | disclosed |
| US-20230391815-A1 | EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2023-12-07 | — | — | US | disclosed |
| US-11345720-B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2022-05-31 | — | — | US | disclosed |
| US-20220106350-A1 | EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2022-04-07 | — | — | US | disclosed |
| CN-107846883-A | The solvent-free phosphorylation of selectivity | 可劳迈戴斯有限公司 | 2018-03-27 | — | — | CN | disclosed |
| US-RE30887-E | HALOGENATED PHOSPHATE ESTERS | OLIN CORPORATION (US) | 1982-03-23 | — | — | US | disclosed |
| EP-0000132-B1 | HALOGEN-SUBSTITUTED ESTERS OF PHOSPHOROUS ACID, POLYMERIC COMPOSITIONS CONTAINING THEM AS REACTIVE FLAME RETARDANTS | Velsicol Chemical Corporation (US) | 1981-08-05 | — | — | EP | disclosed |
| US-4281097-A | USED IN POLYESTERS AND POLYURETHANES | VELSICOL CHEMICAL CORPORATION (US) | 1981-07-28 | — | — | US | disclosed |
| US-4242479-A | CATALYST OF ALUMINUM TRIHALIDE, ORGANOSILOXANE COMPOUND OR ETHER, MAGNESIUM ALCOHOLATE, TITANIUM-HALOGEN AND ORGANOALUMINUM COMPOUNDS | SHOWA YUKA KABUSHIKI KAISHA (JP) | 1980-12-30 | — | — | US | disclosed |
| US-4212757-A | Peroxygen bleaching and compositions therefor | FMC CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |
| US-4180636-A | MAGNESIUM HALIDE, TITANIUM COMPOUND ELECTRON DONOR COMPOUND, TRIALKYL ALUMINUM CATALYST | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1979-12-25 | — | — | US | disclosed |
| EP-0000132-A1 | Halogen-substituted esters of phosphorous acid, polymeric compositions containing them as reactive flame retardants | Velsicol Chemical Corporation (US) | 1979-01-10 | — | — | EP | disclosed |
| US-4133846-A | FIREPROOFING POLYURETHANES AND POLYESTER | VELSICOL CHEMICAL CORPORATION (US) | 1979-01-09 | — | — | US | disclosed |
| US-3992488-A | REDUCES COMBUSTIBILITY OF COTTON FABRICS | OLIN CORPORATION (US) | 1976-11-16 | — | — | US | disclosed |
| US-3987129-A | PROCESS FOR PREPARING BIS(2-HALOALKYL) PHOSPHORO-HALIDATES | OLIN CORPORATION (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163093-A1 | EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF | NAPRT, NAMPT, CD38 | ALDH1A1 2757/4885TP53 3698/4885TDP1 629/4885 |
| US-11345720-B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | NAPRT, NAMPT, CD38 | ALDH1A1 2769/4885TP53 3710/4885TDP1 636/4885 |
| US-20220106350-A1 | EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF | NAPRT, NAMPT, CD38 | ALDH1A1 2769/4885TP53 3710/4885TDP1 636/4885 |
| US-12195494-B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | NAPRT, NAMPT, CD38 | ALDH1A1 2757/4885TP53 3698/4885TDP1 629/4885 |
| US-20230391815-A1 | EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF | NAPRT, NAMPT, CD38 | ALDH1A1 2757/4885TP53 3698/4885TDP1 629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.